Pharma & Biotech News #PharmaBuzz

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Weekly News Recap #Phispers

FDA issues warning letter to Intas' plant in north India; okays Axsome's drug for Alzheimer's-related agitation

In Phispers this week, India’s Intas Pharmaceuticals received a warning letter from the US Food and Drug Administration (...

Impressions : 1497

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

In Phispers this week, Indian drugmaker Sun Pharmaceutical acquired Jersey-based Organon in an all-cash deal valued at about US...

Impressions : 1669

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

Eli Lilly has been on an acquisition spree this year. After buying Ventyx Biosciences, Orna Therapeutics, CrossBridge Bio, and...

Impressions : 1412

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

This week’s Phispers brings you news on how artificial intelligence (AI) is taking centerstage in the world of pharmaceut...

Impressions : 2137

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

FDA issues warning letter to Intas' plant in north India; okays Axsome's drug for Alzheimer's-related agitation

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

Zhejiang Novous's Generics Voriconazole Receives Approval in US

Yichang Humanwell's Generics Bupropion Receives Approval in US

Caplin's Generics Calcium Gluconate Receives Approval in US

Apotex's Evdi Receives Approval in US

Deva Holding' Generics Mirabegron Receives Approval in US

Arvinas Operations' Veppanu Receives Approval in US

Bicoon's Generics Sitagliptin Receives Tentative Approval in US

Micro's Generics Torsemide Receives Approval in US

Incyte Oration's Jakafi Xr Receives Approval in US

Ipca's Generics Propranolol HCl Receives Approval in US

Enforcement Report - Week of May 6, 2026

Active Cosmetics Manufacturing's Receives FDA Warning Letter

Respilon Production S R O's Receives FDA Warning Letter

Intas' Receives FDA Warning Letter

Lexia's Receives FDA Warning Letter

B. Braun Issues Voluntary Recall of Lactated Ringer's Injection

Enforcement Report - Week of April 22, 2026

Veyx-Pharma B.V. Production Fails EDQM Inspection

Produlab Pharma Production Fails EDQM Inspection

Thrive Health and Wellness' Receives FDA Warning Letter

Viatris to Present at BofA Securities 2026 Healthcare Conference

Vanda Pharmaceuticals to Join May 2026 Investor Conferences

Tyra Biosciences To Participate In Upcoming Investor Conferences

Semaglutide Race: Torrent Grabs 38% Market Share

PTC Therapeutics Reports Q1 2026 Results and Update

Precigen to Report Q1 2026 Results and Updates on May 13

Novavax to Present at BofA 2026 Health Care Conference

Nektar Therapeutics Reports First Quarter 2026 Financial Results

LiT Biosciences Launches LiT Protect Botanical Supplement

Lipocine Reports Q1 2026 Financial Results

Semaglutide Race: Torrent Grabs 38% Market Share

Amazon Adds Ozempic Pill To Same-Day Prescription Drug Kiosks

Onesource Supports Second Generic Semaglutide Approval In Canada

Lupin Receives USFDA Approval For Generic Ravicti Oral Liquid

OneSource Partners Win Health Canada Nod for Generic Semaglutide

Mapi Pharma Eyes U.S. Aseptic Plant for Long-Acting Injectables

Accord Healthcare US Relaunches Tadalafil Tablets

GTRI: India Supplies 20% of Global Generics, WTO-Compliant IP

Novo Nordisk Launches Ozempic Oral Pill For Type 2 Diabetes

Aurobindo Pharma's Curateq Receives Health Canada Approval

Tyra Biosciences To Participate In Upcoming Investor Conferences

Nektar Therapeutics Reports First Quarter 2026 Financial Results

Intensity Therapeutics Reports Q1 2026 Results and Update

Ginkgo Bioworks Reports Q1 2026 Results and Scales Auto Lab

Neuland, LIR Partner to Advance Cell Penetrating Peptide Platform

Immunai and AstraZeneca Expand AI-Driven Biomarker Project

EnGene's Shares Crash On Updated Pivotal Bladder Cancer Data

GSK Licenses Halozyme ENHANZE for Subcutaneous Cancer Drugs

Atara, Pierre's Cell Therapy to Get Another Shot at FDA Approval

Zymeworks Reports Q1 2026 Results and Corporate Update

Carbogen Amcis Shanghai Site Passes Surprise NMPA GMP Inspection

India's Emerging Pharma Powerhouses

Lilly Pledges $4.5 Billion More To Indiana Manufacturing Campus

DC Granules: Sitagliptin, Empagliflozin, Dapagliflozin, Metformin

Polyrizon Expands U.S. Patent for Intranasal Delivery Platform

JP Nadda Highlights India's Focus on APIs and Biologics Research

Wanbury Clears Korea FDA Inspection At Patalganga Site

Solara Completes US FDA Inspection At Puducherry Site

RPG Life Sciences Expands API Business, Targets GLP-1 Entry

Formosa Pharma Partners with SERI on Corneal Diseases

CDSCO to Reject Pending Online Applications After 3 Reminders

Makary Announces One-Day Inspection Pilot For Low-Risk Facilities

Foundayo's Liver Failure Blip Impacts Lilly Shares, Analysts

Alkem Labs Gets 7 FDA Observations After Daman Site Inspection

Supreme Court Ask to Intervene in Mail-order Abortion pill fight

NAFDAC Warns of Fake Augmentin 625mg in Nigeria

Several State Still Not File NSQ Data with Central Drug Regulator

InspireMD Initiates Voluntary Recall of CGuard Delivery System

ORS Sales Melt In March After Govt's Stricter Labelling Norms

Patient death prompts FDA pause on Newron's Phase 3 schizophrenia

Xenon MRI Advances as Cardiopulmonary Biomarker at ATS

WHO Says Now Five Confirmed Cruise Ship Hantavirus Cases

Stryker Completes Amplitude Vascular Systems Acquisition